a-Melanocyte-stimulating hormone (av-MSH) is implicated in pigmentation, central nervous system and immune system functions, growth, mitogenisis, and melanoma. Evaluation of these roles has been hindered by the lack of a-MSH antagonists. A combinatorial chemistry-based diffusion assay is used to find random tripeptides that antagonize normal frog and human melanoma MSH receptors and to identify pharmacological groups responsible for receptor interaction. The a-MSH antagonist D-Trp-Arg-Leu-NH2 is used to demonstrate directly the contribution of MSH to normal skin tone in frogs following injection or topical application.a-Melanocyte-stimulating hormone (a-MSH) is potentially involved in numerous important physiological and pathological processes ranging from pigmentation to melanoma (1-9). These roles have not been closely examined, in part at least because of a lack of MSH receptor antagonists. Preliminary reports of compounds that inhibit a-MSH-induced darkening in Rana pipiens skin assays have been made (10), but it is unclear how receptor specific these compounds are or if they are effective in blocking responses to MSH in other species or in vivo. One method typically used to identify antagonists to peptide receptors has been to manipulate the size and sequence of the native peptide hormone. Another method has relied on random screening of thousands of compounds. In this report we describe the use of a combinatorial diffusion assay, an assay that separates molecules in time and space (11), to randomly search for tripeptide and tripeptide-like molecules that antagonize the ca-MSH receptor. The small and uncomplicated structure of these peptide antagonists provides useful structural information for determining receptor interactions.Pigmentary phenomena serve as an example of the many areas of study that stand to benefit from the development of specific MSH receptor antagonists. Pigmentation has long been recognized for playing a role in camouflage and sun protection, but the extent of a-MSH involvement in regulation of basal skin tone is not yet firmly established. It is well known that injection of ca-MSH into a variety of animals including humans causes an increase in skin tone beyond basal levels (1, 2), and there is evidence in some species that plasma a-MSH may correlate with changes in background and animal color (12-14), but these do not provide conclusive information with regard to the extent of MSH involvement in the setting or maintenance of basal tone. Support for the possible involvement of a-MSH in basal skin tone comes primarily from experiments in which removal of the pituitary gland induces pallor in fish, amphibians, and lower mammals (15-18) and from anecdotal clinical reports, given without explanation or speculation, that humans become abnormally pale following the loss of pituitary function due to disease or following hypothesectomy for treatment of metastatic breast cancer (19). However, the complex and far-reaching physiological interactions of the pituitary obscure demonstration...